Open Versus Robotic Retromuscular Ventral Hernia Repair
Launched by PRISMA HEALTH-UPSTATE · Dec 28, 2016
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
All patients presenting to the Greenville Health System Hernia Center who meet the inclusion criteria will be considered for enrollment. Patients who qualify and agree to participate will be randomized 1:1 to robotic retromuscular ventral hernia repair or open retromuscular ventral hernia repair. Data to be collected includes the following: demographic information, medical characteristics, medications, medical and surgical history, operative details, hospital stay data, and patient-reported outcomes via a quality of life questionnaire. Post-operative follow-up will occur at 2 weeks, 6 weeks...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ventral or incisional hernia measuring ≥ 7 cm and ≤ 15 cm.
- • At least one of the following risk factors: Body Mass Index \> 30, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, current smoker (within 1 month)
- Exclusion Criteria:
- • Current abdominal wall infection
- • Presence of ileostomy, colostomy, or ileal conduit
- • Center for Disease Control wound class 3 or 4
- • Hernia defect \< 7 cm or \>15 cm
- • Pregnant women
About Prisma Health Upstate
Prisma Health-Upstate is a leading healthcare provider in South Carolina, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a part of Prisma Health, the largest healthcare system in the state, Prisma Health-Upstate leverages a robust network of clinical expertise, state-of-the-art facilities, and a commitment to excellence in patient care. The organization focuses on a diverse range of therapeutic areas, fostering collaborations that enhance the development of new treatments and technologies. With a patient-centered approach, Prisma Health-Upstate aims to contribute to the scientific community while ensuring the highest standards of safety and quality in all clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Jeremy A Warren, MD
Principal Investigator
Prisma Health-Upstate
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials